George Soros Just Bought These 2 Biotech Stocks. Should You?

The Soros Fund Management opened up smallish positions in the mid-cap biotechs DexCom and AnaptysBio in the most recent quarter.

 
More Headlines

Follow worldbiztoday on Twitter

US Stocks